
Patent Law Weblog
Category: Patent Profiles
-
By Shin Hee Lee* and Anthony D. Sabatelli** — The global hair coloring product market is projected to grow into a 200 billion-dollar industry by 2025. Coty reported in 2017 that more than half of all women color their hair regularly. For example, these figures have reached 62% in the United States, 67% in the…
-
By Steve Kennedy* and Anthony D. Sabatelli** — Over the last decade, antibody-drug conjugates (ADCs) have emerged as a highly promising new class of biopharmaceuticals. By taking advantage of the specificity of monoclonal antibodies and the potency of small-molecule chemotherapy drugs, ADCs have proven to provide a highly effective combination — particularly in the oncology…
-
By Shin Hee Lee* and Anthony D. Sabatelli** — "Your hair is your crowning glory" is an often-quoted phrase with biblical roots.1 Perhaps more importantly, one's hair is a visible barometer of one's health and age. Hair care products are also big business. The global hair care market reached $85.5 billion in annual sales in…
-
By Jing Zhou* and Anthony D. Sabatelli** — Nanoparticles have been used in cancer and other diseases as both diagnostics and therapeutic agents; for example, magnetic nanoparticles for theranostics, quantum dots for bioimaging, nanoparticles as cancer biomarkers and for cancer therapy, and nanoparticles as drug delivery carriers. These applications of nanotechnology not only have attracted…
-
By Shin Hee Lee* and Anthony D. Sabatelli** — The cosmeceutical industry is ever more competitive and continues to grow with a myriad of new cosmeceutical products entering the market every day. Well-established and new companies are busily adapting to new trends created by people's changing tastes. The total revenue of the U.S. cosmeceutical industry…
-
By Josh Bosman — The U.S. Patent and Trademark Office recently issued a notice of allowance for U.S. Application No. 14/199,900, which is entitled "Diagnosis of Solar Lentigo by Nucleic Acid Analysis." The '900 application, which is assigned to the DermTech International, contains claims to a method of detecting melanoma in a human subject. DermTech…
-
By Josh Bosman — The U.S. Patent and Trademark Office recently issued U.S. Patent No. 8,642,270, which is entitled "Prognostic biomarkers to predict overall survival and metastatic disease in patients with triple negative breast cancer." The '270 patent, which is assigned to the VM Institute of Research (Montreal, Canada), contains claims to a method of…
-
By Josh Bosman — The U.S. Patent and Trademark Office recently issued U.S. Patent No. 8,632,983, which is entitled "Biomarkers for pancreatic cancer and diagnostic methods." The '983 patent, which is assigned to the Van Andel Research Institute and the University of Pittsburgh, contains claims to a method for differentiating pancreatic cancer from a benign…
-
By Josh Bosman — Last week, the U.S. Patent and Trademark Office issued U.S. Patent No. 8,628,920, which is entitled "Method for early diagnosis of liver cancer and prediction of metastasis." The '920 patent, which is assigned to National Tsing Hua University in Taiwan, contains claims to a method of determining the risk of liver…
-
By Josh Bosman — Last week, the U.S. Patent and Trademark Office issued U.S. Patent No. 8,623,601, which is entitled "Methods of diagnosing cancer." The '601 patent, which is assigned to Duke University and Cognosci, Inc. (out of the Research Triangle Park in North Carolina), contains claims to a method of predicting or assessing the…